New diabetes clinical trial: A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations

Published on: 2026-03-16T04:00:00Z
Conditions: Cochlear Synaptopathy
Interventions: Drug: CIL001 (Paliroden); Drug: Placebo
Sponsors: Cilcare SAS
Not yet recruiting
https://ift.tt/MC0TwYF